Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.

Methia N, Louache F, Vainchenker W, Wendling F.

Blood. 1993 Sep 1;82(5):1395-401.

2.

Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.

Li Y, Hetet G, Kiladjian JJ, Gardin C, Grandchamp B, Briere J.

Br J Haematol. 1996 Jan;92(1):60-6.

PMID:
8562412
3.

The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets.

Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, et al.

Blood. 1995 Jan 15;85(2):391-401.

4.

Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.

Vigon I, Florindo C, Fichelson S, Guenet JL, Mattei MG, Souyri M, Cosman D, Gisselbrecht S.

Oncogene. 1993 Oct;8(10):2607-15.

PMID:
8397366
5.
6.

Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.

Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.

Exp Hematol. 1997 Sep;25(10):1025-33.

PMID:
9293899
7.

Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.

Taksin AL, Couedic JP, Dusanter-Fourt I, Massé A, Giraudier S, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N.

Blood. 1999 Jan 1;93(1):125-39.

8.

An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis.

Deng B, Banu N, Malloy B, Hass P, Wang JF, Cavacini L, Eaton D, Avraham H.

Blood. 1998 Sep 15;92(6):1981-8.

9.

c-mpl, the thrombopoietin receptor.

Vainchenker W, Methia N, Debili N, Titeux M, Wendling F.

Thromb Haemost. 1995 Jul;74(1):526-8. Review.

PMID:
8578519
10.

Thrombocytopenia in c-mpl-deficient mice.

Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW.

Science. 1994 Sep 2;265(5177):1445-7.

PMID:
8073287
11.

Structure and transcription of the human c-mpl gene (MPL).

Mignotte V, Vigon I, Boucher de Crèvecoeur E, Roméo PH, Lemarchandel V, Chrétien S.

Genomics. 1994 Mar 1;20(1):5-12.

PMID:
8020956
12.

Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.

Rosti V, Bergamaschi G, Lucotti C, Danova M, Carlo-Stella C, Locatelli F, Tonon L, Mazzini G, Cazzola M.

Blood. 1995 Nov 1;86(9):3387-93.

13.

Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.

Szczylik C, Skórski T, Malaguarnera L, Hetman J, Chen ST, Calabretta B.

Folia Histochem Cytobiol. 1996;34(3-4):129-34.

PMID:
8967957
14.

Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.

Ratajczak MZ, Kuczynski WI, Sokol DL, Moore JS, Pletcher CH Jr, Gewirtz AM.

Blood. 1995 Sep 15;86(6):2161-7.

15.

A functional analysis of protooncogene Vav's role in adult human hematopoiesis.

Luger SM, Ratajczak J, Ratajczak MZ, Kuczynski WI, DiPaola RS, Ngo W, Clevenger CV, Gewirtz AM.

Blood. 1996 Feb 15;87(4):1326-34.

16.

Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.

Duensing S, Duensing A, Meran JG, Kreft A, Büsche G, Ganser A, Georgii A.

Mol Pathol. 1999 Jun;52(3):146-50.

17.
18.
20.

Expression of the c-mpl proto-oncogene in human hematologic malignancies.

Vigon I, Dreyfus F, Melle J, Viguié F, Ribrag V, Cocault L, Souyri M, Gisselbrecht S.

Blood. 1993 Aug 1;82(3):877-83.

Items per page

Supplemental Content

Write to the Help Desk